Evaluation Of Common Intensive Care Unit Infections In An Indian ICU

Not yet recruiting

• Conditions: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified,

• Registration Number: CTRI/2022/09/045544
• Lead Sponsor: Not Applicable

Brief Summary

Incidence of nosocomal infections in theIntensive Care Unit (ICU) has

been reported to be higher than in generalinpatient hospital population.

Most published studies regardingepidemiology, microbiology of ICU-

acquired infections  such as ventilator associated pneumonia(VAP),

catheter associated urinary tractinfections (CAUTI) and catheter related

bloodstream infections (CRBSI)  have come from industrialized westerncountries.

Variations in the incidence, microbiology, andresistance patterns in Indian ICU’s are not well understood yet. There is limited literatureregarding  ICU infections in the Indian setting, and hence, westernguidelines are being extrapolated for the management of theseinfections. Till date we don’t have any robust data to formulate our ownAntibiotic stewardship programme.

Hence, we sought to perform this singlecentred, epidemiological

prospective study which included evaluatingthe epidemiology and

resistance patterns of above mentioned ICUinfections at our centre

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-09-14
• Study Start: 2022-09-22

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with ICU stay ≥48 h and having any one of the infections – VAP Ventilator Associated Pneumonia Catheter Associated Urinary Tract Infection Central Line Related Blood Stream Infection CRBSI.

Exclusion Criteria

Patients aged <18 years of age Index ICU stay < 48 hours Re admissions to the ICU within the same hospitalisation.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation Of Incidence Of ICU acquired Infections at our Tertiary care critical care department	If culture positive then till shift out from ICU or Death of patient

Secondary Outcome Measures

Name	Time	Method
Evaluation of the morbidity and mortality associated with these ICU acquired Infections	If culture positive then till shift out from ICU or Discharge of patient

Trial Locations

Locations (1)

Grant Medical Foundation Ruby Hall Clinic; 🇮🇳 Pune, MAHARASHTRA, India

Grant Medical Foundation Ruby Hall Clinic

🇮🇳Pune, MAHARASHTRA, India

Dr Piyush Dhawad

Principal investigator

8983248382

drpiyushdhawad297@gmail.com